• Explore /
  • Poster
  • / Bone metabolism biomarkers (BMB) and progression-free survival (PFS) in men with metastatic hormone-sensitive prostate cancer (HSPC): SWOG S1216, a phase III trial of androgen deprivation therapy (ADT) with or without orteronel.

Bone metabolism biomarkers (BMB) and progression-free survival (PFS) in men with metastatic hormone-sensitive prostate cancer (HSPC): SWOG S1216, a phase III trial of androgen deprivation therapy (ADT) with or without orteronel.

Abstract Poster

Authors

Primo Lara, Jr

Primo Lara Jr.

University of California, Sacramento, CA

Primo Lara Jr., Edward Mayerson , Erik Gertz , Catherine Tangen , Amir Goldkorn , Marta Van Loan , Maha H. A. Hussain , Shilpa Gupta , Jingsong Zhang , Przemyslaw Twardowski , David I. Quinn , Nicholas J. Vogelzang , Ian Murchie Thompson Jr., Neeraj Agarwal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Epidemiology/Outcomes

Clinical Trial Registration Number

NCT01809691

Citation

J Clin Oncol 38: 2020 (suppl; abstr 5523)

DOI

10.1200/JCO.2020.38.15_suppl.5523

Abstract #

5523

Poster Bd #

104

Abstract Disclosures

Similar Posters

First Author: Nicolas Sayegh

First Author: Mamta Parikh

First Author: Primo "Lucky" N. Lara Jr.

First Author: Primo N Lara Jr.